Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-97-001528
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
9
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 IMMULOGIC PHARMACEUTICAL FORM 10-K 10-K 157587
2 SEVERANCE & SETTLEMENT AGREEMENT 12/4/96 EX-10.31 15993
3 SEVERANCE & SETTLEMENT AGREEMENT 3/4/97 EX-10.32 26424
4 AGREEMENT DATED 10-25/96 EX-10.33 15397
5 AMENDMENT NO.1 TO RIGHTS AGREEMENT EX-10.34 5666
6 CONSULTATION AGREEMENT EX-10.35 25898
7 LETTER AGREEMENT EX-10.38 1206
8 CONSENT OF COOPERS & LYBRAND EX-23.1 1064
9 FINANCIAL DATA SCHEDULE EX-27 2538
  Complete submission text file 0000950135-97-001528.txt   254064
Mailing Address 610 LINCOLN ST WALTHAM MA 02154
Business Address 610 LINCOLN ST WALTHAM MA 02154 6174666000
IMMULOGIC PHARMACEUTICAL CORP /DE (Filer) CIK: 0000873731 (see all company filings)

EIN.: 133397957 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19117 | Film No.: 97569443
SIC: 2834 Pharmaceutical Preparations